AI Generated Content

This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.

Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drug

SUMMARY

AI Generated Content
  • Alembic gets USFDA tentative OK for Bosutinib 400mg tablets.
  • Treats Ph+ chronic myelogenous leukemia (CML) in adults.
  • Equivalent to Bosulif 400mg, Alembic already has 100/500mg OK'd.
AD
Other Interesting Stories
AD